Effects of local administration of clodronate on orthodontic tooth movement and root resorption in rats

European Journal of Orthodontics

Volumn 26, Issue 5, 2004, Pages 469-473

  Liu, Lin ^a   Igarashi, Kaoru ^a   Haruyama, Naoto ^a   Saeki, Shuichi ^a   Shinoda, Hisashi ^a   Mitani, Hideo ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID;

ANIMAL; ARTICLE; DRUG EFFECT; JAW; MALE; OSTEOCLAST; PERIODONTAL DISEASE; RAT; TOOTH DISEASE; WISTAR RAT;

ALVEOLAR PROCESS; ANIMALS; CLODRONIC ACID; MALE; OSTEOCLASTS; RATS; RATS, WISTAR; ROOT RESORPTION; TOOTH MOVEMENT;

EID: 16644368865     PISSN: 01415387     EISSN: None     Source Type: Journal    
DOI: 10.1093/ejo/26.5.469     Document Type: Article

References (35)

1. Adachi H, Igarashi K, Mitani H, Shinoda H 1994 Effects of topical administration of a bisphosphonate (risedronate) on orthodontic tooth movement in rats. Journal of Dental Research 73: 1478-1486
2. Alhashimi N, Frithiof L, Brudvik P, Bakhiet M 2001 Orthodontic tooth movement and de novo synthesis of proinflammatory cytokines. American Journal of Orthodontics and Dentofacial Orthopedics 119: 307-312
3. 2 during experimental tooth movement. European Journal of Orthodontics 13: 255-263
4. Chumbley A B, Tuncay O C 1986 The effect of indomethacin (an aspirin-like drug) on the rate of orthodontic tooth movement. American Journal of Orthodontics 89: 312-314
5. Dunford J E et al. 2001 Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. Journal of Pharmacology and Experimental Therapeutics 296: 235-242
6. Elomaa I et al. 1992 Effects of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer. International Urology and Nephrology 24: 159-166
7. Felix R, Bettex J D, Fleisch H 1981 Effect of diphosphonates on the synthesis of prostaglandins in cultured calvaria cells. Calcified Tissue International 33: 549-552
8. Fleisch H 2000 Bisphosphonates in bone disease: from the laboratory to the patient, 4th edn. Academic Press, San Diego, pp. 40-41
9. Fleisch H, Reszka A, Rodan G, Rogers M 2002 Bisphosphonates, mechanisms of action. In: Bilezikian J P, Raisz L G, Rodan G A (eds) Principles of bone biology, 2nd edn. Academic Press, San Diego, pp. 1361-1385
10. Frith J C, Mönkkönen J, Auriola S, Mönkkönen H, Rogers M J 2001 The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate. Arthritis and Rheumatism 44: 2201-2210
11. Giuliani N, Pedrazzoni M, Passeri G, Girasole G 1998 Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. Scandinavian Journal of Rheumatology 27: 38-41
12. Halasy-Nagy J M, Rodan G A, Reszka A A 2001 Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone 29: 553-559
13. Hayashi K, Igarashi K, Miyoshi K, Shinoda H, Mitani H 2002 Involvement of nitric oxide in orthodontic tooth movement in rats. American Journal of Orthodontics and Dentofacial Orthopedics 122: 306-309
14. Igarashi K, Mitani H, Adachi H, Shinoda H 1994 Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movement in rats. American Journal of Orthodontics and Dentofacial Orthopedics 106: 279-289
15. Igarashi K, Adachi H, Mitani H, Shinoda H 1996 Inhibitory effect of the topical administration of a bisphosphonate (risedronate) on root resorption incident to orthodontic tooth movement in rats. Journal of Dental Research 75: 1644-1649
16. 2 synthesis in the clonal osteoblast-like cell line MC3T3-E1. Prostaglandins, Leukotrienes and Essential Fatty Acids 56: 121-125
17. Iwasaki L R, Haack J E, Nickel J C, Reinhardt R A, Petro T M 2001 Human interleukin-1 beta and interleukin-1 receptor antagonist secretion and velocity of tooth movement. Archives of Oral Biology 46: 185-189
18. Lowney J J, Norton L A, Shafer D M, Rossomando E F 1995 Orthodontic forces increase tumor necrosis factor alpha in the human gingival sulcus. American Journal of Orthodontics and Dentofacial Orthopedics 108: 519-524
19. Makkönen N, Hirvonen M R, Teräväinen T, Savolainen K, Mönkkönen J 1996 Different effects of three bisphosphonates on nitric oxide production by RAW 264 macrophage-like cells in vitro. Journal of Pharmacology and Experimental Therapeutics 277: 1097-1102
20. Makkönen N et al. 1999 Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite. European Journal of Pharmaceutical Sciences 8: 109-118
21. Mönkkönen J, Pennanen N, Lapinjoki S, Urtti A 1994 Clodronate (dichloromethylene bisphosphonate) inhibits LPS-stimulated IL-6 and TNF production by RAW 264 cells. Life Sciences 54: PL229-234
22. Mönkkönen J, Similä J, Rogers M J 1998 Effects of tiludronate and ibandronate on the secretion of proinflammatory cytokines and nitric oxide from macrophages in vitro. Life Sciences 62: PL95-102
23. Ngan P, Wilson S, Shanfeld J, Amini H 1994 The effect of ibuprofen on the level of discomfort in patients undergoing orthodontic treatment. American Journal of Orthodontics and Dentofacial Orthopedics 106: 88-95
24. Österman T, Kippo K, Lauren L, Hannuniemi R, Sellman R 1995 Effect of clodronate on established collagen-induced arthritis in rats. Inflammation Research 44: 258-263
25. Pecherstorfer M et al. 2000 Effect of first treatment with aminobisphosphonates pamidronate and ibandronate on circulating lymphocyte subpopulations. Journal of Bone and Mineral Research 15: 147-154
26. Pennanen N, Lapinjoki S, Urtti A, Mönkkönen J 1995 Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro. Pharmaceutical Research 12: 916-922
27. Plosker G L, Goa K L 1994 Clodronate: a review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs 47: 945-982
28. Richards P J, Williams B D, Williams A S 2001 Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate. Rheumatology 40: 978-987
29. Roberts W E 1994 Bone physiology, metabolism, and biomechanics in orthodontic practice. In: Graber T M, Vanarsdall, Jr R L (eds) Orthodontics, current principles and techniques, 2nd edn. Mosby, St. Louis, pp. 193-234
30. Rogers M J et al. 2000 Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88: 2961-2978
31. Saito M, Saito S, Ngan P W, Shanfeld J, Davidovitch Z 1991 Interleukin 1 beta and prostaglandin E are involved in the response of periodontal cells to mechanical stress in vivo and in vitro. American Journal of Orthodontics and Dentofacial Orthopedics 99: 226-240
32. Shinoda H, Adamek G, Felix R, Fleisch H, Schenk R, Hagan P 1983 Structure-activity relationships of various bisphosphonates. Calcified Tissue International 35: 87-99
33. Shirazi M, Nilforoushan D, Alghasi H, Dehpour A-R 2002 The role of nitric oxide in orthodontic tooth movement in rats. Angle Orthodontist 72: 211-215
34. Yamasaki K, Miura F, Suda T 1980 Prostaglandin as a mediator of bone resorption induced by experimental tooth movement in rats. Journal of Dental Research 59: 1635-1642
35. Zhou D, Hughes B, King G J 1997 Histomorphometric and biochemical study of osteoclasts at orthodontic compression sites in the rat during indomethacin inhibition. Archives of Oral Biology 42: 717-726